Consort Medical

Hemel Hempstead, United Kingdom Founded: 1946 • Age: 80 yrs Listed Acquired By Recipharm
Portfolio of products for airway management and drug delivery

About Consort Medical

Consort Medical is a Healthcare company based in Hemel Hempstead (United Kingdom) founded in 1946, and was acquired by Recipharm in November 2019. Portfolio of products for airway management and drug delivery. The company has 12 employees. Consort Medical has completed 1 acquisition, including Aesica. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices. Its legal entity is CONSORT MEDICAL LIMITED.

Company details

Consort Medical is a healthcare company that through its subsidiaries is focused on medical device technologies for drug delivery and hospital products for the management of patient airways. Aesica Pharmaceuticals and Bespak are subsidiaries of Consort Medical. Aesica is a pharmaceutical CDMO serving pharmaceutical companies with active pharmaceutical ingredient (API) and finished dose formulation development and manufacturing services. Bespak is a company active in the development and manufacture of drug delivery devices, serving pharmaceutical companies with inhaler and auto-injector technologies and development and manufacturing services.

  • Headquarters Hemel Hempstead, United Kingdom
  • Employees 12
  • Stage Acquired
  • Sectors
    Healthcare
  • Website consortmedical.com
  • Social LinkedIn X
  • Acquired by Recipharm (Nov 2019)
  • Legal Name Consort Medical Limited
  • Date of Incorporation 22 Mar, 1946
  • Jurisdiction KING'S LYNN, NORFOLK, ENGLAND
Operational Areas
Key Metrics
  • Annual Revenue
    $415.33 M (USD)
    6
    as on Dec 31, 2018
  • Net Profit
    -$241.67 M (USD)
    -927
    as on Dec 31, 2020
  • EBITDA
    -$257.65 M (USD)
    -1108
    as on Dec 31, 2020
  • Investors
  • Employee Count
    12
  • Investments & Acquisitions
  • Acquired by
    Recipharm

    (Nov 2019)

Investors in Consort Medical

Consort Medical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Recipharm.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Pharmaceutical development and manufacturing services are offered contractually.
1995recipharm.comJordbro, Sweden
Premium access

Investor details for Consort Medical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Consort Medical

Consort Medical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Aesica.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Contract development and manufacturing organisation (CDMO) for APIs and finished dose forms
aesica-pharma.comNewcastle Upon Tyne, United Kingdom2004Sep 2014$364.82M
Premium access

Complete acquisition details for Consort Medical

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Consort Medical

4 dated milestones of Consort Medical across 73 years, from founding to its latest funding, stage changes and deals.

  1. Founded Consort Medical is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Aesica.
  4. Exit Acquired by Recipharm.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Consort Medical

Premium access

Complete news archive for Consort Medical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Consort Medical

Consort Medical was founded in 1946.

Consort Medical is headquartered in Hemel Hempstead, United Kingdom.

Consort Medical has 12 employees.

Annual revenue of Consort Medical is $415.33M as on Dec 31, 2018.

Consort Medical is a healthcare company that through its subsidiaries is focused on medical device technologies for drug delivery and hospital products for the management of patient airways. Aesica Pharmaceuticals and Bespak are subsidiaries of Consort Medical. Aesica is a pharmaceutical CDMO serving pharmaceutical companies with active pharmaceutical ingredient (API) and finished dose formulation development and manufacturing services. Bespak is a company active in the development and manufacture of drug delivery devices, serving pharmaceutical companies with inhaler and auto-injector technologies and development and manufacturing services.

Consort Medical has made 1 acquisition, including Aesica.

Consort Medical has 1 investor. Key investors include Recipharm.

Consort Medical operates through Consort Medical Limited.

Yes. Consort Medical was acquired by Recipharm in November 2019.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available